Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.68 CAD | +1.17% | +2.12% | +56.68% |
Mar. 15 | Transcript : Cipher Pharmaceuticals Inc., Q4 2023 Earnings Call, Mar 15, 2024 | |
Mar. 14 | Tranche Update on Cipher Pharmaceuticals Inc.'s Equity Buyback Plan announced on November 15, 2023. | CI |
Sales 2024 * | 28.87M 21.05M | Sales 2025 * | 29.33M 21.39M | Capitalization | 207M 151M |
---|---|---|---|---|---|
Net income 2024 * | 12M 8.75M | Net income 2025 * | 13M 9.48M | EV / Sales 2024 * | 7.17 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 7.05 x |
P/E ratio 2024 * |
17.5
x | P/E ratio 2025 * |
19.8
x | Employees | 5 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 55.49% |
Latest transcript on Cipher Pharmaceuticals Inc.
1 day | -0.12% | ||
1 week | +0.82% | ||
Current month | -0.12% | ||
1 month | +5.80% | ||
3 months | +45.42% | ||
6 months | +95.44% | ||
Current year | +54.87% |
Managers | Title | Age | Since |
---|---|---|---|
Craig Mull
CEO | Chief Executive Officer | - | 19-03-25 |
Bryan Jacobs
DFI | Director of Finance/CFO | - | 22-08-14 |
James Bowen
IRC | Investor Relations Contact | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Harold Wolkin
BRD | Director/Board Member | 72 | 16-08-07 |
Douglas N. Deeth
BRD | Director/Board Member | 76 | 23-06-20 |
Craig Mull
CEO | Chief Executive Officer | - | 19-03-25 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-02 | 8.68 | +1.17% | 9 688 |
24-05-01 | 8.58 | -0.12% | 5,653 |
24-04-30 | 8.59 | +0.82% | 39,964 |
24-04-29 | 8.52 | +0.24% | 10,210 |
24-04-26 | 8.5 | 0.00% | 3,900 |
Delayed Quote Toronto S.E., May 01, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+54.87% | 150M | |
+33.25% | 699B | |
+25.86% | 571B | |
-3.55% | 364B | |
+18.16% | 326B | |
+4.36% | 286B | |
+15.13% | 236B | |
+5.03% | 198B | |
-10.31% | 194B | |
-3.69% | 149B |
- Stock Market
- Equities
- CPH Stock